P95--LINKING DSB REPAIR AND CELL CYCLE CHECKPOINTS
P95——连接 DSB 修复和细胞周期检查点
基本信息
- 批准号:6182188
- 负责人:
- 金额:$ 28.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-05-01 至 2003-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Nijmegen Breakage Syndrome (NBS) is an autosomal recessive disorder characterized by marked cancer predisposition, sensitivity to ionizing radiation, and defects in DNA damage dependent cell cycle checkpoints. Because the cellular phenotypes of NBS strongly resemble those of cells established from ataxia telangiectasia (AT) patients, this syndrome has been described as an AT variant syndrome although it is genetically distinct. We showed that NBS is attributable to deficiency in an intrinsic member of the hMre11/hRad50 protein complex, referred to herein as p95. We have established that this complex, which is uniformly distributed in the nucleus prior to irradiation, relocalizes to sites of DNA damage in the nuclei of cells treated with ionizing radiation, and is restored to uniform distribution upon completion of DNA repair. The association of the complex with DNA damage, in conjunction with the finding that cellular responses to ionizing radiation are abrogated by p95 deficiency lead to the hypothesis that the complex acts to sense and signal the presence of DNA damage in irradiated cells. In this proposal, we will examine the function of p95 to address this hypothesis, and to elucidate its potential role the repair of ionizing radiation-induced DNA damage as part of the Mre11/Rad50 complex. We propose to carry out phenotypic analyses of p95 deficient cells expressing variants of p95 to define functionally important domains of the protein. To examine phenotypes that are not assayable in cultured cells and to assess genetic interactions of p95, p95 deficient mice will be constructed. Of particular interest in this regard are the genetic and functional interactions between p95 and ATM which will be assessed by breeding of p95 and ATM deficient mice. These studies will provide important information regarding the relative contributions of p95 and ATM in the cellular and organismal responses to ionizing radiation. In this proposal, p95 is examined from three complementary perspectives. First, at the cellular level, second, at the molecular level, and third, in vivo through the derivation of a munbs1 mutant mouse.
奈梅亨断裂综合征(NBS)是一种常染色体隐性遗传疾病,其特征在于显著的癌症易感性、对电离辐射的敏感性和DNA损伤依赖性细胞周期检查点的缺陷。 由于NBS的细胞表型与共济失调毛细血管扩张症(AT)患者的细胞表型非常相似,因此该综合征被描述为AT变异综合征,尽管它在遗传上是不同的。 我们发现,NBS是由于缺乏内在成员的hMre 11/hRad 50蛋白复合物,在本文中称为p95。 我们已经确定,这种复合物,这是均匀分布在细胞核中的辐射前,重新定位到网站的DNA损伤的细胞核中的电离辐射处理,并恢复到均匀分布后完成DNA修复。 该复合物与DNA损伤的关联,以及对电离辐射的细胞反应被p95缺陷所废除的发现,导致了该复合物的作用是感知和信号辐射细胞中DNA损伤的存在的假设。在这个提议中,我们将研究p95的功能,以解决这一假设,并阐明其潜在的作用,修复电离辐射诱导的DNA损伤的Mre 11/Rad 50复合物的一部分。 我们建议进行表型分析的p95缺陷细胞表达的p95的变体,以定义功能上重要的结构域的蛋白质。 为了检查在培养细胞中不可测定的表型并评估p95的遗传相互作用,将构建p95缺陷型小鼠。 在这方面特别感兴趣的是p95和ATM之间的遗传和功能相互作用,这将通过繁殖p95和ATM缺陷小鼠来评估。这些研究将提供关于p95和ATM在细胞和生物体对电离辐射的反应中的相对贡献的重要信息。 在本提案中,从三个互补的角度对p95进行了审查。 第一,在细胞水平,第二,在分子水平,第三,在体内通过munbs 1突变小鼠的衍生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John HJ Petrini其他文献
John HJ Petrini的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John HJ Petrini', 18)}}的其他基金
FASEB SRC on Genetic Recombination and Genome Rearrangements
FASEB SRC 关于基因重组和基因组重排
- 批准号:
8199893 - 财政年份:2011
- 资助金额:
$ 28.57万 - 项目类别:
Project 3: Oncogene Activation and DNA Damage Response-Mediated Epigenetic Changes
项目3:癌基因激活和DNA损伤反应介导的表观遗传变化
- 批准号:
10132252 - 财政年份:2000
- 资助金额:
$ 28.57万 - 项目类别:
P95--LINKING DSB REPAIR AND CELL CYCLE CHECKPOINTS
P95——连接 DSB 修复和细胞周期检查点
- 批准号:
6386489 - 财政年份:1999
- 资助金额:
$ 28.57万 - 项目类别:
Regulation of the DNA damage response by the Mre11 complex
Mre11 复合物对 DNA 损伤反应的调节
- 批准号:
7737365 - 财政年份:1999
- 资助金额:
$ 28.57万 - 项目类别:
Regulation of the DNA damage response by the Mre11 complex
Mre11 复合物对 DNA 损伤反应的调节
- 批准号:
8415942 - 财政年份:1999
- 资助金额:
$ 28.57万 - 项目类别:
Regulation of the DNA damage response by the Mre11 complex
Mre11 复合物对 DNA 损伤反应的调节
- 批准号:
7535601 - 财政年份:1999
- 资助金额:
$ 28.57万 - 项目类别:
相似海外基金
DNA repair pathway coordination during damage processing
损伤处理过程中 DNA 修复途径的协调
- 批准号:
10748479 - 财政年份:2024
- 资助金额:
$ 28.57万 - 项目类别:
CAREER: Mechanisms and consequences of epigenome-recruited DNA repair systems in plants
职业:植物中表观基因组招募的 DNA 修复系统的机制和后果
- 批准号:
2338236 - 财政年份:2024
- 资助金额:
$ 28.57万 - 项目类别:
Continuing Grant
Multifaceted regulation of the DNA repair machinery and suppression of aberrant transcription by telomere proteins
DNA 修复机制的多方面调控和端粒蛋白异常转录的抑制
- 批准号:
2246561 - 财政年份:2023
- 资助金额:
$ 28.57万 - 项目类别:
Standard Grant
Elucidation of the molecular link between DNA repair and mitochondrial nucleic acid metabolism
阐明DNA修复和线粒体核酸代谢之间的分子联系
- 批准号:
23K07078 - 财政年份:2023
- 资助金额:
$ 28.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Structural studies for understanding the mechanism of DNA repair in chromatin
了解染色质 DNA 修复机制的结构研究
- 批准号:
23H05475 - 财政年份:2023
- 资助金额:
$ 28.57万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Biochemistry of Eukaryotic Replication Fork and DNA Repair
真核复制叉的生物化学和 DNA 修复
- 批准号:
10550045 - 财政年份:2023
- 资助金额:
$ 28.57万 - 项目类别:
Modeling the Responsiveness of Sensitive Populations to Genotoxic Agents Using DNA Repair Inhibitors
使用 DNA 修复抑制剂模拟敏感人群对基因毒性药物的反应性
- 批准号:
10734425 - 财政年份:2023
- 资助金额:
$ 28.57万 - 项目类别:
A role of balanced sex hormone in DNA repair in human melanocytes
平衡性激素在人类黑素细胞 DNA 修复中的作用
- 批准号:
10666307 - 财政年份:2023
- 资助金额:
$ 28.57万 - 项目类别:
Natural products inhibitors targeting homology-directed DNA repair for cancer therapy
针对癌症治疗的同源定向 DNA 修复的天然产物抑制剂
- 批准号:
10651048 - 财政年份:2023
- 资助金额:
$ 28.57万 - 项目类别:














{{item.name}}会员




